Patents for A61P 27 - Drugs for disorders of the senses (53,017)
05/2012
05/03/2012CA2815436A1 Ophthalmic compositions
05/03/2012CA2815170A1 Pyridine derivative and medicinal agent
05/03/2012CA2814439A1 Dosing regimes for the treatment of ocular vascular disease
05/02/2012EP2447265A1 Novel thiophene carboxamide derivative and medicinal use of same
05/02/2012EP2447264A1 N-substituted-cyclic amino derivative
05/02/2012EP2446890A1 High viscosity macromolecular compositions for treating ocular conditions
05/02/2012EP1861403B1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
05/02/2012EP1716851B1 Thioamides and salts thereof and cytokine production inhibitors containing both
05/02/2012EP1693060B1 Therapeutic or preventive agents for ischemic neuropathy
05/02/2012EP1534668B1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
05/02/2012EP1487431B1 Preventing and/or treating cardiovascular disease and/or associated heart failure
05/02/2012CN102439007A Amide derivative
05/02/2012CN102438979A New crystals of a benzoylbenzeneacetamide derivative
05/02/2012CN102438647A Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor
05/02/2012CN102438614A Pyrone analogs for therapeutic treatment
05/02/2012CN102430060A Cold and hot temperature difference method for processing tall gastrodia tuber
05/02/2012CN102429911A Application of ZSTK474 to preparation of medicine for treating autoimmune diseases
05/02/2012CN102429908A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
05/02/2012CN102429885A DC (Directly compressible)-xylitol and preparation method thereof
05/02/2012CN102429862A Sustained-release povidone iodine eye drops
05/02/2012CN102166328B Traditional Chinese medicine preparation for curing visual fatigue, teen-age amblyopia, pseudomyopia and myopia
05/02/2012CN101306128B Decoction for treating otitis media suppurativa acuta
05/01/2012US8168637 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes
05/01/2012US8168620 Combination of azelastine and steroids
05/01/2012US8168616 Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
05/01/2012US8168189 Protein A compositions and methods of use
05/01/2012CA2495542C Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease
05/01/2012CA2404212C A process for the preparation of epothilone analogs and intermediates
04/2012
04/26/2012WO2011119008A3 Peptides for promoting angiogenesis and an use thereof
04/26/2012US20120101167 Treatment of ocular and cerebral ischemia
04/26/2012US20120101160 Use of chemical chaperones to treat glaucoma caused by misfolded or misprocessed proteins
04/26/2012US20120101129 Methylphenidate Derivatives and Uses of Them
04/26/2012US20120101120 Pure isomers of tritoqualine
04/26/2012US20120101112 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/26/2012US20120101075 Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 Adrenergic Receptor
04/26/2012US20120101074 Method and medication for prevention and treatment of ocular hypertension and glaucoma
04/26/2012US20120101068 Diphenyl sulfide derivatives and medicines containing same as active ingredient
04/26/2012US20120101061 Compositions and methods for the treatment of inflammation
04/26/2012US20120101046 Prophylactic or therapeutic agent for retinal disease and method for prophylaxis or therapy of retinal disease using jnk (c-jun amino-terminal kinase) - inhibitory peptide, and use of the peptide
04/26/2012US20120101033 Retinitis pigmentosa treatment
04/26/2012US20120101028 Anti-inflammatory compounds and uses thereof
04/26/2012US20120101026 Compounds For Enzyme Inhibition
04/26/2012US20120101025 Compounds For Enzyme Inhibition
04/26/2012US20120100215 Muller stem cells
04/26/2012US20120100184 Synthesis of 1-amino-1,3,3,5,5,-cyclohexane mesylate
04/26/2012US20120100153 Stable and soluble antibodies
04/26/2012US20120100136 Methods for treating or preventing ophthalmological diseases
04/26/2012US20120100133 Use of anti-cd20 antibody for treating primary intraocular lymphoma
04/26/2012US20120100127 Method to Increase the Absorption of Unsaturated Fatty Acids by Human Infants
04/26/2012US20120100110 Physiological methods for isolation of high purity cell populations
04/25/2012EP2444402A1 Compound having spiro-bonded cyclic group and use thereof
04/25/2012EP2444401A1 Novel imidazopyridine compound
04/25/2012EP2444395A1 Substituted isoquinoline derivative
04/25/2012EP2444079A1 Compositions and Methods for Treatment of Eye Disorders
04/25/2012EP2444065A1 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
04/25/2012EP2442820A1 Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders
04/25/2012EP2442818A1 Methods of treating outer eye disorders using high orp acid water and compositions thereof
04/25/2012EP2442812A1 Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
04/25/2012EP2442790A1 Aqueous pharmaceutical compositions containing borate-polyol complexes
04/25/2012EP2442647A2 Dithiol compounds, derivatives, and uses therefor
04/25/2012EP2442645A1 Choline esters
04/25/2012EP2442644A1 Opsin-binding ligands, compositions and methods of use
04/25/2012EP2146727B1 High viscosity macromolecular compositions for treating ocular conditions
04/25/2012EP1719774B1 Therapeutic agent for diabetic macular edema
04/25/2012EP1650205B1 Cyclohexanecarboxylic acid compound
04/25/2012EP1601767B1 USE OF siRNA TO SUPPRESS EXPRESSION OF EIF-5A1 IN THE TREATMENT OF GLAUCOMA
04/25/2012EP1357912B1 Photodynamic therapy of occult choroidal neovascularization linked to age-related macular degeneration
04/25/2012CN102428080A 神经营养因子活性参与的疾病的治疗或预防剂 Neurotrophic agent for treating or preventing diseases associated with the activity of Factor
04/25/2012CN102427819A A3 adenosine receptor agonists for the reduction of intraocular pressure
04/25/2012CN102427816A Pharmaceutical composition for treatment or prevention of ophthalmic diseases
04/25/2012CN102423420A Traditional Chinese medicine combination for vision rehabilitation and preparation method thereof
04/25/2012CN102423380A 一种清肝胆实火燥湿的药物组合 A pharmaceutical composition hepatobiliary real fire to clear dampness
04/25/2012CN102423349A 一种治疗急性传染性结膜炎的中药 A traditional Chinese medicine treatment of acute infectious conjunctivitis
04/25/2012CN102423332A 用于治疗青光眼的药物及其制备方法 Glaucoma medications and preparation methods for
04/25/2012CN102423307A 去氢厄弗酚在制备抗肿瘤及抑制肿瘤新生血管生成药物、保健食品或化妆品中的应用 Dehydroepiandrosterone Ephesus phenol in the preparation of anti-tumor and inhibit tumor angiogenesis drugs, health food or cosmetics applications
04/25/2012CN101850118B 加载于无机盐载体的脂溶性光敏剂的制备方法及其在制备光动力疗法药物中的应用 Preparation of inorganic carrier loaded on fat-soluble photosensitizer and its application in the manufacture of a medicament for photodynamic therapy
04/25/2012CN101849953B 炎症性细胞因子产生游离抑制剂 Inflammatory cytokine production inhibitor free
04/25/2012CN101810563B 他克莫司眼用在体凝胶制剂及其制备方法 Tacrolimus ophthalmic gel formulations used in the body and its preparation method
04/25/2012CN101524394B 雀嘴茶制剂及其应用 Sparrow mouth tea preparation and its application
04/25/2012CN101495452B Ep2激动剂 Ep2 agonists
04/25/2012CN101434649B 一种环七肽及其制备方法和应用 A cyclic heptapeptide and its preparation method and application
04/25/2012CN101347620B 一种药物组合物及其在制备治疗青光眼的药物中的应用 A pharmaceutical composition for the treatment of glaucoma and pharmaceutical application in the preparation of
04/24/2012US8163932 Substituted indolealkanoic acids
04/24/2012US8163723 Combination of azelastine and steroids
04/24/2012US8163719 Regulators of the hedgehog pathway, compositions and uses related thereto
04/24/2012US8163305 Targeted cross-linked nanoparticles and their use in vivo gene delivery
04/24/2012CA2551411C Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it
04/24/2012CA2550302C L-(-)-moprolol l-(+)-tartrate
04/24/2012CA2486537C 4-(substituted cycloalkylmethyl)imidazole-2-thiones, 4-(substituted cycloalkenylmethyl)imidazole-2-thiones, 4-(substituted cycloalkylmethyl)imidazol-2-ones and 4-(substituted cycloalkenylmethyl)imidazol-2-ones and related compounds
04/24/2012CA2433807C Hydrophobic polyamine analogs and methods for their use
04/24/2012CA2433582C Peptides having inhibiting activity on the production of nitric oxide
04/19/2012WO2012051313A2 Ophthalmic formulations, methods of manufacture and methods of normalizing meibomian gland secretions
04/19/2012WO2012050151A1 Acylbenzene derivative
04/19/2012WO2012048893A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
04/19/2012WO2012048721A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
04/19/2012WO2012009171A3 Compositions and methods of treatment of corneal endothelium disorders
04/19/2012WO2011155803A3 Novel compound having hearing protection effects
04/19/2012WO2011133566A3 Repairing bruch's membrane with hydrogels
04/19/2012WO2011109384A3 Biodegradable polymers for lowering intraocular pressure
04/19/2012US20120096569 Anti-il-6 antibodies,compositions, methods and uses
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 531